{"id":"https://openalex.org/W2416630416","doi":null,"title":"Propelling Immunotherapy Combinations Into the Clinic.","display_name":"Propelling Immunotherapy Combinations Into the Clinic.","publication_year":2015,"publication_date":"2015-12-01","ids":{"openalex":"https://openalex.org/W2416630416","mag":"2416630416","pmid":"https://pubmed.ncbi.nlm.nih.gov/26680224"},"language":"en","primary_location":{"id":"pmid:26680224","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26680224","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology (Williston Park, N.Y.)","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090445265","display_name":"Nishan Tchekmedyian","orcid":"https://orcid.org/0000-0003-1298-0993","observed_orcids":["https://orcid.org/0000-0003-1298-0993"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nishan Tchekmedyian","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Jhanelle E Gray","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jhanelle E Gray","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064826649","display_name":"Ben Creelan","orcid":"https://orcid.org/0000-0002-2728-8070","observed_orcids":["https://orcid.org/0000-0002-2728-8070"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benjamin C Creelan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080538468","display_name":"Alberto Chiappori","orcid":"https://orcid.org/0000-0003-0810-7104","observed_orcids":["https://orcid.org/0000-0003-0810-7104"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alberto A Chiappori","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032171890","display_name":"Amer A. Beg","orcid":"https://orcid.org/0000-0003-3834-774X","observed_orcids":["https://orcid.org/0000-0003-3834-774X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amer A Beg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090789911","display_name":"Hatem Hussein Soliman","orcid":"https://orcid.org/0000-0001-6644-2264","observed_orcids":["https://orcid.org/0000-0001-6644-2264"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hatem Soliman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030440776","display_name":"Bradford A. Perez","orcid":"https://orcid.org/0000-0001-5725-195X","observed_orcids":["https://orcid.org/0000-0001-5725-195X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bradford A Perez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5046273815","display_name":"Scott Joseph Antonia","orcid":"https://orcid.org/0000-0002-6686-3824","observed_orcids":["https://orcid.org/0000-0002-6686-3824"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Scott J Antonia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.6013,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":{"value":0.86279745,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":99},"biblio":{"volume":"29","issue":"12","first_page":"990","last_page":"1002"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.8299999833106995},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9919999837875366},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.7710000276565552},{"id":"https://openalex.org/keywords/dual-immune-checkpoint-blockade","display_name":"dual immune checkpoint blockade","score":0.9049999713897705},{"id":"https://openalex.org/keywords/indoleamine-2-3-dioxygenase-inhibition","display_name":"indoleamine 2,3-dioxygenase inhibition","score":0.9480000138282776},{"id":"https://openalex.org/keywords/adoptive-t-cell-therapy","display_name":"adoptive T cell therapy","score":0.9860000014305115},{"id":"https://openalex.org/keywords/t-cell-engineering","display_name":"T cell engineering","score":0.8980000019073486},{"id":"https://openalex.org/keywords/therapeutic-vaccines","display_name":"therapeutic vaccines","score":0.8790000081062317},{"id":"https://openalex.org/keywords/small-molecule-inhibitors","display_name":"small molecule inhibitors","score":0.9179999828338623},{"id":"https://openalex.org/keywords/radiotherapy","display_name":"radiotherapy","score":0.8960000276565552},{"id":"https://openalex.org/keywords/t-cell-migration","display_name":"T cell migration","score":0.8190000057220459},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.9739999771118164},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.7720000147819519},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.9800000190734863},{"id":"https://openalex.org/keywords/clinical-trial-design","display_name":"clinical trial design","score":0.9139999747276306}],"concepts":[{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6854022741317749},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.6716920137405396},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.6289931535720825},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5894472599029541},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.578080952167511},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5256313681602478},{"id":"https://openalex.org/C21705690","wikidata":"https://www.wikidata.org/wiki/Q2907609","display_name":"CTLA-4","level":4,"score":0.45930609107017517},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.45775046944618225},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.4550538659095764},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.4517768919467926},{"id":"https://openalex.org/C90375314","wikidata":"https://www.wikidata.org/wiki/Q3537484","display_name":"Adoptive cell transfer","level":4,"score":0.44598639011383057},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.4442942142486572},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3879704177379608},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3512517511844635},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.17437279224395752},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.0841120183467865}],"mesh":[{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:26680224","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26680224","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology (Williston Park, N.Y.)","raw_type":"Journal Article"},{"id":"mag:2416630416","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26680224","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2480743627","https://openalex.org/W7172302322","https://openalex.org/W2586357468","https://openalex.org/W2913942589","https://openalex.org/W2924956524","https://openalex.org/W4241147974","https://openalex.org/W2573278233","https://openalex.org/W4206840735","https://openalex.org/W2417250557","https://openalex.org/W4372342026"],"abstract_inverted_index":{"Immune":[0],"checkpoint":[1,104,113,153],"inhibitors":[2],"produce":[3],"durable":[4,162],"long-term":[5],"survival":[6],"in":[7,171],"some":[8],"patients":[9],"with":[10,115,155],"advanced":[11],"melanoma":[12],"and":[13,19,55,65,70,90,94,135,148,161],"lung":[14],"cancer.":[15],"Better":[16],"immune":[17,25,87,103,112,152],"targets":[18],"combination":[20,110],"strategies":[21],"can":[22],"harness":[23],"the":[24,29,48,59,63,67,76,83,109,156],"system":[26],"by":[27,82],"supporting":[28],"three":[30],"elements":[31],"of":[32,40,43,58,111,120,124,158,175],"a":[33,173],"successful":[34],"T-cell":[35,53,72,128],"antitumor":[36,44,163],"response:":[37],"(A)":[38],"generation":[39],"sufficient":[41],"numbers":[42],"T":[45],"cells":[46],"within":[47,75],"lymphoid":[49,60],"compartment;":[50],"(B)":[51],"effective":[52],"trafficking":[54],"extravasation":[56],"out":[57],"compartment,":[61],"through":[62],"bloodstream,":[64],"into":[66],"tumor":[68,77],"microenvironment;":[69],"(C)":[71],"effector":[73],"function":[74],"microenvironment":[78],"that":[79,98],"is":[80],"characterized":[81],"ability":[84],"to":[85,144],"bypass":[86],"checkpoints,":[88],"soluble":[89],"metabolic":[91],"inhibitory":[92,95],"factors,":[93],"cells.":[96],"Strategies":[97],"hold":[99],"promise":[100],"include":[101],"dual":[102],"blockade,":[105],"as":[106,108],"well":[107],"blockade":[114],"costimulatory":[116],"receptor":[117],"agonists,":[118],"enhancers":[119],"innate":[121],"immunity,":[122],"inhibition":[123],"indoleamine":[125],"2,3-dioxygenase,":[126],"adoptive":[127],"transfer/T-cell":[129],"engineering,":[130],"therapeutic":[131],"vaccines,":[132],"small-molecule":[133],"inhibitors,":[134,154],"radiation":[136],"therapy.":[137],"Novel,":[138],"rational":[139],"clinical":[140],"trial":[141],"designs":[142],"seek":[143],"combine":[145],"targeted":[146],"agents":[147],"one":[149],"or":[150],"more":[151],"goal":[157],"producing":[159],"deep":[160],"responses,":[164],"which":[165],"thus":[166],"far":[167],"have":[168],"been":[169],"observed":[170],"only":[172],"minority":[174],"patients.":[176]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":7}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}